Remove sales-marketing event
article thumbnail

STAT+: Electronic health record maker NextGen Healthcare to pay $31 million to resolve fraud claims

STAT

The settlement caps a lengthy investigation that cast a harsh light on NextGen’s efforts to gain market share in the sharp-elbowed business of selling electronic health records software. The government said the company also gave tickets to sporting events and other entertainment to induce referrals and sales.

article thumbnail

Viseven at Digital Pharma East 2023: Contributing to the Future

Viseven

Digital Pharma East is a captivating event for professionals who want to improve their expertise in advertising, sales, brand marketing, customer experience, digital marketing, PR, product marketing, social media, and strategic operations.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Reshaping events in pharma

pharmaphorum

Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events. The changing events model. The changing events model.

article thumbnail

Pharma Marketers: Drive Registrations for Your Next Event [INFOGRAPHIC]

Pharma Marketing Network

With our growing audience of pharma and healthcare professionals, the Pharma Marketing Network (PMN) leverages its experience in helping drive registrations for top-rated events and conferences that attracts diverse populations at scale. Company Email *.

article thumbnail

6 Digital Tools at the Center of Healthcare Digitalization [INFOGRAPHIC]

Pharma Marketing Network

Download this infographic and learn which 6 digital tools are at the center of digitalization and how the will influence the future of Pharma marketing in 2021 and beyond. The post 6 Digital Tools at the Center of Healthcare Digitalization [INFOGRAPHIC] appeared first on Pharma Marketing Network. Company Email *.

article thumbnail

Novo Nordisk blockbuster Ozempic boasts 23% sales surge in 2023

Pharmaceutical Technology

Novo Nordisk’s leading drug Ozempic (semaglutide) is forecast to demonstrate a sales growth of 23% in 2023. Ozempic’s forecast 2023 sales of $12.5bn consolidate its position as the dominant market leader, with projected sales in 2023 54% greater than closest competitor Trulicity (dulaglutide) by Eli Lilly, which anticipates sales of $8bn.

Dosage 52
article thumbnail

Sanofi, Amgen acknowledge Horizon interest as J&J steps back

pharmaphorum

The Irish rules stipulate that any company that receives takeover interest must disclose the event to the public, and within 45 days of the first announcement (in this case 10 January), must also say whether any of the potential buyers has a “firm” interest in concluding a deal. billion expected from sales of Krystexxa in the US.

98